藥 名
永康
柳營
佳里
|
更新日期：08/12/2024 10:45:10
Cefoperazone/Sulbactam1g/1g
|
現行藥品外觀
11B097
健保
自費
|
中文名：博益欣注射劑(2g)
健保碼：AC58156212
廠 牌：台灣東洋
|
|
藥理分類
J01DD62
|
【Antibacterials for systemic use】
Third-generation cephalosporins
|
|
|
藥理作用
|
|
|
Product name
|
Brosym (2g/V)針
|
|
Dosage form
|
Inj.
Each vial contains Cefoperazone/Sulbactam 1g/1g
|
|
Administration & Dosage
|
IV,
【Adult】
●Infectious disease of abdomen, neutropenia associated with infectious disease, postoperative wound infection, urinary tract infectious disease： 2g/2g (total 4g) q12 h.
【Pediatric】
●Infectious disease of abdomen, neutropenia associated with infectious disease, postoperative wound infection, urinary tract infectious disease：
*Mild-to-moderate infections: 20mg/20mg/kg/day ~40 mg/40mg/kg/day in 2-4 divided doses
*Serious infections: 80mg/80 mg/kg/day in 2-4 divided doses.
|
|
建議給藥途徑
|
IV推、IV滴
|
|
腎功能劑量建議
|
ClCr >60：4g Q12H
ClCr 30-59：4g Q12H
ClCr <30：2g Q12H
CVVH：4g Q12H
hemodialysis：2g Q12H
|
|
肝功能劑量建議
|
無特別標註
|
|
Contraindication
|
Hypersensitivity to cephalosporins.
|
|
Precaution
|
Monitor for coagulopathy (Prolonged PT, INR), and bleeding event.
|
|
Adverse reaction
|
【>1 % or unknown】Increased serum transaminases, seizure, PT prolong, hypotension, phlebitis, pain at injection site.
【<1%】Skin rash, urticaria, anemia, oral candidiasis, headache, hematuria
【0.1- 1%】 Skin rash, thrombocythemia, leukopenia, eosinophilia, diarrhea,,nausea, vomiting, drug fever
|
|
Pregnancy Category
|
B / 可能安全
|
|
Notes
|
1. Patients with moderate to severe liver cirrhosis (child-pugh B-C), or use anti-coagulant as warfarin is not recommended to use cefoperazone due to concern of PT prolongation, coagulopathy, and bleeding risk.
2. Na content: 124.6mg/vial, 5.41meq/vial
|
|
相關連結
|
|
|
磨粉及剝半提示 |
無特別標註
|
|
給藥及保存方式 |
以10ml D.W配製後,應立即使用
最終輸注體積不得低於20ml
IV滴, 15-30分鐘
稀釋後室溫可保存6hr,
2-8℃可保存48hr。
|
針劑相容溶液
*為文獻資料 |
G5W, N.S.
| 途徑 | 溶解液 | 溶解液量(ml) | 溶解後總量(ml) | | IV滴 | Water for inj. (20ml/A) 針. | 10.00 | 11.60 |
|
| 健保給付規定 |
無
|
舊藥品外觀
|
中文名：博益欣注射劑(2g)
廠 牌：台灣東洋
|